Lymphoid Malignancies
📧 Sign up to get email alerts when something new happens for Lymphoid Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Study of AUR104 in Patients With Relapsed/Refractory Lymphoid Malignancies (VIJAY-1) [Phase 1]
Phase 1 study of AUR104 in select relapsed/refractory lymphoid malignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies [Phase 1]
Phase 1 trial update of RTA 402 (bardoxolone methyl) in patients with advanced solid tumors or lymphoid malignancies; the study has complete…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of escalating doses of AGS67E as monotherapy in subjects with relapsed o…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Ph2 NK Cell Enriched DCIs w/wo RLR9 Agonist, DUK-CPG-001 From Donors Following Allogeneic SCT [Phase 2]
Phase 2 trial update on natural killer (NK) cell-enriched dendritic cell vaccines with or without a RLR9 agonist (DUK-CPG-001) from donors a…
-
CLINICAL_TRIALS trial_result · 2022-11-23Clinical Trial Update: Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 trial update on pralatrexate plus romidepsin in relapsed/refractory lymphoid malignancies and multiple myeloma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial of ABT-263 in relapsed or refractory lymphoid malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-21Clinical Trial Update: PT-CY With or Without Low-dose ATG for Lymphoid Malignancies Undergoing Allo-HSCT [Phase 2]
Phase 2 trial evaluating PT-CY with or without low-dose ATG for lymphoid malignancies undergoing allogeneic hematopoietic stem cell transpla…
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Roll Over Study to Provide Idelalisib to Participants Previously Treated With the Investigational PI3Kδ Inhibitor, GS-9820 [Phase 4]
A Phase 4 roll-over trial evaluating idelalisib for participants previously treated with GS-9820 (another PI3Kδ inhibitor) has been terminat…
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Fludarabine/Busulfan and Cyclophosphamide Conditioning for Adult Lymphoid Malignancies [Phase 2]
Phase 2 trial update evaluating fludarabine/busulfan and cyclophosphamide conditioning for adult lymphoid malignancies has been completed.
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-thymocyte Globulin for Older Patients With Relapsed Lymphoid Malignancies [Phase 2]
Phase 2 trial of a non-myeloablative preparative regimen using total lymphoid irradiation and anti-thymocyte globulin for older patients wit…
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System [Phase 1, Phase 2]
A phase 1/2 trial of intrathecal rituximab for lymphoid malignancies involving the central nervous system was terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Cord Blood Transplantation in Patients With Advanced Lymphoid Malignancies [Phase 2]
Phase 2 clinical trial update on cord blood transplantation for patients with advanced lymphoid malignancies who lack an HLA-identical or mi…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies [Phase 1]
A Phase 1b study evaluating GS-9820 in subjects with lymphoid malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies [Phase 1]
A Phase 1 study of HGS1029 in relapsed or refractory lymphoid malignancies was terminated.
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies [Phase 1]
Phase 1 study of RTA 402 (bardoxolone methyl) in advanced solid tumors and lymphoid malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-28Clinical Trial Update: Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid Malignancies [Phase 1]
Phase 1 trial update evaluating CHR-2845 for safety and tolerability in hematological diseases and lymphoid malignancies. The study status i…
-
CLINICAL_TRIALS trial_result · 2011-08-01Clinical Trial Update: Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders [Phase 2]
A Phase 2 study of HQK-1004 in combination with valganciclovir for Epstein-Barr virus–associated lymphoid malignancies and lymphoproliferati…